Wired Herald

​Know in Electronic Drug Delivery Systems Market by Top Leading Vendors like AstraZeneca, Insulet Corporation, Medtronic, F.Hoffmann-La Roche Ltd, Merck Group, Amgen and Others

Press release   •   Jan 13, 2020 05:06 EST

The global ​Electronic Drug Delivery Systems Market Size is set to reach over US$ 12.1 billion by 2027 and will grow at CAGR 8.9% during the forecast period 2019-2027. Acumen Research and Consulting, Latest Research Report on titled “Electronic Drug Delivery Systems Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 –2027”.

In the coming years, the global Electronic Drug Delivery Systems Market will continue exhibiting growth at a stable pace. The report offers a comprehensive overview of the market, covering growth drivers as well as restraints. It reveals hidden opportunities across key segments. Furthermore, the report highlights prevailing threats in the market. It is compiled with the most relevant information on the market to help companies determine their future growth strategies.

Information thus included in the report is obtained using diverse primary and secondary research methods. The report also includes interview of industry veterans. Their opinion is given due weightage in the study. In addition to this, the report includes statistics taken from various international organizations. This is done with the intent of studying the global market for the period starting from 2019 to 2027. These figures are reached using in-depth qualitative and quantitative analysis.

Competitive Landscape

In order to offer an executive level blueprint of the global Electronic Drug Delivery Systems Market, the report studies in detail the prevailing competitive landscape. The nature of competition prevailing in the global market is studied. Factors resulting into competitive rivalry among leading players are gauges as well. In this section, the report includes information obtained from various companies. Information on their product portfolio and pricing strategy is included in this section. Furthermore, the report highlights the impact of strategies adopted by these companies on this market.

Bargaining power of supplier and buyers are calculated using Porter’s five forces analysis. Furthermore, the study, helps at calculating the threat from close substitutes as well as new entrants.

Download a Free Sample Copy@ https://www.acumenresearchandconsulting.com/request-sample/1597

List of Companies

To offer a comprehensive overview, the report profiles some of the most prominent names in the industry.The market share of the global Electronic Drug Delivery Systems Market is dominated by companies like AstraZeneca, Insulet Corporation, Medtronic, F.Hoffmann-La Roche Ltd, Merck Group, Amgen, Bayer AG, Companion Medical, Tandem Diabetes Care, and Novo Nordisk A/S. They are studied on the basis of their corporate policies, product portfolio, pricing strategies, recent mergers and acquisition, and various other criteria. Furthermore, recent developments witnessed in these companies in terms of recent investment, product launches, and collaborations are studied in the report in detail.

The strengths and weaknesses of the companies profiled are studied in detail. Furthermore, the report offers scope for analysing threats and opportunities existing in the market for the companies profiled.

Geography

The global Electronic Drug Delivery Systems Market can be segmented into Europe, Asia Pacific, North America, Latin America, and the Middle East and Africa.

Among key regional segments, the market is likely to witness lucrative growth opportunities in developed economies. The presence of a well-developed healthcare network is expected to support the growth of the market in these countries. Developed countries have attained the status of early adopters. While several leading companies have presence here, they are gradually shifting focus to capitalize on the prevailing opportunities in the emerging nations.

Various factors are supporting the growth witnessed across these countries. Firstly, the rise in spread of awareness is expected to bode well for the Electronic Drug Delivery Systems Market in emerging economies. Furthermore, in Asia Pacific government support towards the sector as well as investment towards expanding the healthcare and pharmaceutical industries is increasing. This is expected to drive the Electronic Drug Delivery Systems Market in Asia Pacific.

To offer an executive-level blueprint, the report calculates market share held by each of these regions. Furthermore, it identifies the leading region in this market.

Segments

The report segments the Electronic Drug Delivery Systems Marketin terms of various parameters. The leading segment in each of these categories is identified in the study. Furthermore, their potential CAGR is calculated. In addition to this, the report offers insights into growth drivers and key restraints that are likely to impact the market across various segments.

Market Segmentations as below:

Market By Product

  • Electronic Wearable Infusion Pumps
  • Electronic Injection Pens
  • Electronic Inhalers
  • Autoinjectors

Market By Indication

  • Diabetes
  • Cardiovascular Diseases
  • Multiple Sclerosis
  • COPD &Asthma

Market By Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Key Takeaways:

  • What is the market size in 2018 and the growth rate of this research report?
  • What is the market drivers, restrains, opportunities governing the global Electronic Drug Delivery Systems Market?
  • Which is the largest and the fastest growing segments in this report?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Pure Cashmere
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Electronic Drug Delivery Systems Market By Product
1.2.2.1. Global Electronic Drug Delivery Systems Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Electronic Drug Delivery Systems Market Revenue Share By Product in 2017
1.2.2.3. Electronic Wearable Infusion Pumps
1.2.2.4. Electronic Injection Pens
1.2.2.5. Electronic Inhalers
1.2.2.6. Autoinjectors
1.2.3. Electronic Drug Delivery Systems Market By Indication
1.2.3.1. Global Electronic Drug Delivery Systems Market Revenue and Growth Rate Comparison By Indication (2015-2026)
1.2.3.2. Global Electronic Drug Delivery Systems Market Revenue Share By Indication in 2017
1.2.3.3. Diabetes
1.2.3.4. Cardiovascular Diseases
1.2.3.5. Multiple Sclerosis
1.2.3.6. COPD &Asthma
1.2.4. Electronic Drug Delivery Systems Market By Geography
1.2.4.1. Global Electronic Drug Delivery Systems Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Electronic Drug Delivery Systems Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Electronic Drug Delivery Systems Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Electronic Drug Delivery Systems Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Electronic Drug Delivery Systems Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Electronic Drug Delivery Systems Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Pure Cashmere Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Pure Cashmere Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Pure Cashmere Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Pure Cashmere Major Manufacturers in 2017

CHAPTER 4. ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY PRODUCT
4.1. Global Pure Cashmere Revenue By Product
4.2. Electronic Wearable Infusion Pumps
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Electronic Injection Pens
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Electronic Inhalers
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Autoinjectors
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY INDICATION
5.1. Global Pure Cashmere Revenue By Indication
5.2. Diabetes
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Cardiovascular Diseases
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Multiple Sclerosis
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. COPD &Asthma
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY COUNTRY
6.1. North America Electronic Drug Delivery Systems Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Electronic Drug Delivery Systems Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Electronic Drug Delivery Systems Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY COUNTRY
7.1. Europe Electronic Drug Delivery Systems Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Electronic Drug Delivery Systems Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY COUNTRY
8.1. Asia-Pacific Electronic Drug Delivery Systems Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Electronic Drug Delivery Systems Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY COUNTRY
9.1. Latin America Electronic Drug Delivery Systems Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Electronic Drug Delivery Systems Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
9.4. Mexico
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY COUNTRY
10.1. Middle East & Africa Electronic Drug Delivery Systems Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East & Africa Electronic Drug Delivery Systems Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. GCC
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
10.4. South Africa
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)
10.5. Rest of Middle East & Africa
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Indication, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE
11.1. AstraZeneca
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Insulet Corporation
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Medtronic
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. F.Hoffmann-La Roche Ltd
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. Merck Group
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Amgen
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. Bayer AG
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Companion Medical
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. Tandem Diabetes Care
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. Novo Nordisk A/S
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
11.11. Others
11.11.1. Company Snapshot
11.11.2. Overview
11.11.3. Financial Overview
11.11.4. Product Portfolio
11.11.5. Key Developments
11.11.6. Strategies

CHAPTER 12. RESEARCH APPROACH
12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1597

Contact Us:

Acumen Research and Consulting

Phone: +1 407 915 4157

Email: sales@acumenresearchandconsulting.com

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.